Pages that link to "Q67920558"
Jump to navigation
Jump to search
The following pages link to Cellular pharmacokinetics of daunorubicin: relationships with the response to treatment in patients with acute myeloid leukemia (Q67920558):
Displaying 16 items.
- A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin (Q33540751) (← links)
- Micellar electrokinetic chromatographic analysis for in vitro accumulation of anthracyclines enhanced by inhibitors of cell membrane transporter-proteins in cancer cells (Q33795090) (← links)
- Inverse relationship between leukaemic cell burden and plasma concentrations of daunorubicin in patients with acute myeloid leukaemia (Q34829963) (← links)
- Pharmacology of Anticancer Drugs in the Elderly Population (Q35579412) (← links)
- Daunorubicin pharmacokinetics and the correlation with P-glycoprotein and response in patients with acute leukaemia (Q36080042) (← links)
- New approaches for the detection of minimal residual disease in acute myeloid leukemia (Q37738472) (← links)
- Clinical pharmacokinetics-pharmacodynamics of anticancer drugs (Q38649105) (← links)
- Clinical pharmacology of cancer chemotherapy in children. (Q38700644) (← links)
- Pharmacology of cancer chemotherapy in the older person. (Q41313391) (← links)
- Use of plasma cytotoxic activity to model cytotoxic pharmacodynamics of anticancer drugs (Q41705952) (← links)
- Uptake of anthracyclines in vitro and in vivo in acute myeloid leukemia cells in relation to apoptosis and clinical response (Q43263561) (← links)
- Disposition of liposomal daunorubicin during cotreatment with cytarabine in patients with leukaemia (Q44526734) (← links)
- Population pharmacokinetics of Daunorubicin in adult patients with acute myeloid leukemia. (Q51395611) (← links)
- Multidrug-resistant acute leukemia cells are responsive to prolonged exposure of daunorubicin: implications for liposome-encapsulated daunorubicin. (Q54135665) (← links)
- High percentage of CD34-positive cells in autologous AML peripheral blood stem cell products reflects inadequate in vivo purging and low chemotherapeutic toxicity in a subgroup of patients with poor clinical outcome (Q78800310) (← links)
- Carbonyl reductase 1 expression influences daunorubicin metabolism in acute myeloid leukemia (Q84075373) (← links)